Impact of Anti-CD20 Antibodies on the Incidence of Secondary Cancers in Patients Treated for Chronic Lymphocytic Leukemia

被引：0
|
作者：
Guidez, Stephanie [1 ]
Demarquette, Helene [1 ]
Nudel, Morgane [1 ]
Le Grand, Charline [2 ]
Boyle, Eileen [1 ]
Herbaux, Charles [1 ]
Facon, Thierry [1 ]
Cazin, Bruno [1 ]
Morschhauser, Franck [1 ]
机构：
[1] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France
[2] CHRU Lille, Hop Claude Huriez, F-59037 Lille, France
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] IMPACT OF ANTI-CD20 ANTIBODIES ON THE INCIDENCE OF SECONDARY CANCERS IN PATIENTS TREATED FOR CHRONIC LYMPHOCYTIC LEUKEMIA
    Guidez, S.
    Demarquette, H.
    Nudel, M.
    Le Grand, C.
    Herbaux, C.
    Facon, T.
    Cazin, B.
    Morschhauser, F.
    HAEMATOLOGICA, 2016, 101 : 443 - 444
  • [2] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Jain, Preetesh
    O'Brien, Susan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 169 - 182
  • [3] Chronic Lymphocytic Leukemia and anti-CD20 monoclonal antibodies
    Reslan, Lina
    Dalle, Stephane
    Mestas, Jean-Louis
    Tournebize, Cindy
    Dumontet, Charles
    BULLETIN DU CANCER, 2010, 97 : S60 - S60
  • [4] The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Evers, Mitchell
    Jak, Margot
    Leusen, J. H. W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 973 - 982
  • [5] Place of monoclonal antibodies (anti-CD52, anti-CD20) in chronic lymphocytic leukemia
    Divine, Marine
    HEMATOLOGIE, 2006, 12 : 35 - 38
  • [6] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
    Bagacean, Cristina
    Zdrenghea, Mihnea
    Tempescul, Adrian
    Cristea, Victor
    Renaudineau, Yves
    IMMUNOTHERAPY, 2016, 8 (05) : 569 - 581
  • [7] Apoptotic induction by anti-CD20 antibodies in chronic lymphocytic leukemia: comparison of rituximab and obinutuzumab
    Reslan, Lina
    Dalle, Stephane
    Herveau, Stephanie
    Perrial, Emeline
    Dumontet, Charles
    LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 188 - 190
  • [8] COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Principe, Maria Ilaria Del
    Sportoletti, Paolo
    Innocenti, Idanna
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD ADVANCES, 2025, 9 (01) : 162 - 165
  • [9] Anti-CD20 and anti-CD52 monoclonal antibodies enhance cytotoxicity of bortezomib against chronic lymphocytic leukemia cells
    Smolewski, P
    Duechler, M
    Linke, A
    Cebula, B
    Grzybowska-Izydorczyk, O
    Shehata, M
    Robak, T
    BLOOD, 2005, 106 (11) : 833A - 834A
  • [10] What is the status of novel anti-CD20 antibodies for chronic lymphocytic leukemia and are they set to leave rituximab in the shadows?
    Chaudhry, Maria
    Cheson, Bruce D.
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (06) : 733 - 742
12345